Stockholm - Delayed Quote SEK
Elicera Therapeutics AB (publ) (ELIC.ST)
5.45
0.00
(0.00%)
At close: May 20 at 5:29:42 PM GMT+2
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.3 | 0.2 |
| Low Estimate | 0 | 0 | -0.3 | 0.2 |
| High Estimate | 0 | 0 | -0.3 | 0.2 |
| Year Ago EPS | -- | -- | -0.51 | -0.3 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 6.65M | 52.35M |
| Low Estimate | -- | -- | 3.6M | 26.8M |
| High Estimate | -- | -- | 9.7M | 77.9M |
| Year Ago Sales | -- | -- | 7.13M | 6.65M |
| Sales Growth (year/est) | -- | -- | -6.71% | 687.22% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.3 | 0.2 |
| 7 Days Ago | 0 | 0 | -0.5 | 0.6 |
| 30 Days Ago | 0 | 0 | -0.5 | 0.6 |
| 60 Days Ago | 0 | 0 | -1.08 | 1 |
| 90 Days Ago | 0 | 0 | -1.08 | -0.34 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ELIC.ST | -- | -- | 41.18% | 166.67% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Related Tickers
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3850
-2.78%
INIT.ST Initiator Pharma A/S
3.7100
-4.87%
P0F.F Egetis Therapeutics AB (publ)
0.2720
+1.68%
DEX.ST DexTech Medical AB
5.20
-13.33%
1CVAC.MI CureVac N.V.
3.6140
+9.05%
SYNACT.ST SynAct Pharma AB
18.40
+2.45%
1GDA.BE Zevra Therapeutics Inc
7.70
-1.28%
1GDA.F Zevra Therapeutics, Inc.
7.80
+1.96%
APTA.ST Aptahem AB (publ)
1.1600
+33.64%
8EM.F Editas Medicine, Inc.
1.2720
-5.07%